BIOG_B: third-quarter organic sales rose 23% as margin reached 33%
BIOG_B's Q3: organic sales up 23%, operating profit up 54%, operating margin at 33%. Figures as reported by TradingView.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
BIOG_B's third-quarter sales grew 23% excluding currency effects. Operating profit climbed 54%, and the operating margin came in at 33%. For January through September, organic sales increased 16%, while the adjusted operating margin reached 31%.
Both segments contributed to the growth, with Adult Health standing out as the main driver. According to the report, the increase spanned all regions. Operating cash flow, however, declined due to changes in working capital.
The information was published by TradingView as a summary of the original document, which is AI-generated.
why it matters
A combination of fast sales growth and a high margin typically supports investor interest in the stock. The drop in operating cash flow is worth watching, though, since markets judge earnings quality by how well profit converts into cash, not only by the headline result.
market impact
BIOG_B: strong results support the stock, but weaker cash flow raises questions about earnings quality
tags
instruments
sources
- BIOG_B: Q3 organic sales rose 23%, lifting operating margin to 33% — TradingView, 22 October 2026 at 06:12 UTC
- BIOG_B: Q3 sales rose 23% and EBIT 54%, lifting the margin to 33% — TradingView, 22 October 2026 at 06:17 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗